Nikko Asset Management Americas’s Biogen BIIB Stock Holding History

Nikko Asset Management Americas’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-900	Closed	-$282K	–	281
2017 Q3	$282K	Sell	900 -500	-36%	-$148K	0.01%	186
2017 Q2	$380K	Hold	1,400	–	–	0.02%	199
2017 Q1	$383K	Buy	1,400 +700	+100%	+$198K	0.03%	191
2016 Q4	$199K	Sell	700 -500	-42%	-$148K	0.02%	250
2016 Q3	$376K	Sell	1,200 -800	-40%	-$237K	0.03%	182
2016 Q2	$478K	Hold	2,000	–	–	0.05%	157
2016 Q1	$508K	Buy	2,000 +700	+54%	+$185K	0.06%	142
2015 Q4	$401K	Hold	1,300	–	–	0.05%	150
2015 Q3	$362K	Hold	1,300	–	–	0.04%	148
2015 Q2	$515K	Hold	1,300	–	–	0.04%	142
2015 Q1	$561K	Hold	1,300	–	–	0.04%	146
2014 Q4	$445K	Hold	1,300	–	–	0.03%	154
2014 Q3	$429K	Hold	1,300	–	–	0.03%	143
2014 Q2	$414K	Hold	1,300	–	–	0.02%	144
2014 Q1	$382K	Sell	1,300 -100	-7%	-$31.7K	0.02%	139
2013 Q4	$391K	Buy	+1,400	New	+$362K	0.01%	139

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Nikko Asset Management Americas's BIIB Position: Q4 2017 in Review

Nikko Asset Management Americas sold out of Biogen (BIIB) in Q4 2017, closing a stake of 900 shares — an estimated $282K sold.

Nikko Asset Management Americas first reported a position in BIIB in Q4 2013 and held it in 16 quarters. The position peaked at $561K in Q1 2015. 1,123 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

Nikko Asset Management Americas reported no remaining Biogen position as of Q4 2017 after selling out during the quarter.
Nikko Asset Management Americas sold 900 Biogen shares in Q4 2017, an estimated $282K.
Nikko Asset Management Americas first reported a position in Biogen in Q4 2013 and held it in 16 quarters.
Nikko Asset Management Americas's Biogen position peaked at $561K in Q1 2015.
1,123 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Nikko Asset Management Americas's 13F filing for Q4 2017, filed 14 Feb 2018.